logo
Women's health is under attack – protecting it is the smart investment for everyone

Women's health is under attack – protecting it is the smart investment for everyone

Telegraph19-05-2025

As conflict, disaster and displacement rise globally and aid budgets shrink, one truth is becoming harder to ignore. Women and girls are losing access to basic health services, putting their lives at risk. And the starker reality is that the long-term impacts will be felt far beyond national borders.
Earlier this year, the United States withdrew over US$330 million in funding from UNFPA, the UN's sexual and reproductive health agency. A third of that cut directly affects countries in Asia and the Pacific, home to over 60 per cent of the global population and some of the world's most fragile humanitarian settings.
What impact is this having? In Afghanistan, 6.3 million people will lose access to essential health care, most of them women and girls, including lifesaving maternal health services. Hundreds of health centres operating in remote areas and mobile clinics are being forced to close. In Bangladesh, 600,000 people, including Rohingya refugees, will be cut off from safe childbirth, contraception and care for survivors of rape. Health workers are being laid off. Supplies are running out. Lives are at stake.
This is not just a funding gap. It is a collapse of global solidarity, and it is already reversing decades of progress on women's health and rights. The consequences will include rising maternal deaths, violence and growing instability in already fragile regions. This is the most serious funding crisis the international development system has ever faced.
Earlier this month, I met a young mother in Bamyan, Afghanistan, who had walked for hours in labour to reach a small rural clinic. One of the few still operational with UNFPA support. There was no ambulance, no doctor. The sole midwife operating the clinic told me, 'If I had left, a mother or baby would have died.' This is what's at risk when global funding disappears. Not just services but survival itself – particularly of the poorest and most vulnerable.
UNFPA provides a lifeline to women and girls. We train and pay the salaries of midwives in some of the most challenging places on earth. We supply life-saving medical kits, contraceptives and clinical equipment to overstretched hospitals and the hard-to-reach communities. These tools make survival possible. Today, those shipments and services are being halted.
Without supplies, health workers and midwives cannot save lives. Without funding, UNFPA cannot stay and deliver. We are well past the point of this simply being charity. It is common sense.
When women and girls can access healthcare, they are more likely to finish school, join the workforce and raise healthier families. Without these services, poverty deepens, gender inequality widens and health systems buckle under the strain.
There is also a strong economic case. Every £1 invested in family planning delivers more than £6 in returns, by reducing health costs, preventing unintended pregnancies, and boosting women's participation in the workforce. This aligns with one of the UK's key development priorities – to boost economic growth.
Partnership, not pity
The UK has long been a global leader in health and development. Now, in the wake of the US withdrawal, that leadership is more critical than ever. As UNFPA's second-largest donor and a key supporter of our Supplies Partnership – which delivers modern contraceptives and maternal health supplies to the world's most underserved women and girls – the UK has helped prevent 89 million unintended pregnancies and 1.6 million child deaths since 2008. In 2024 alone, UK funding in Asia and the Pacific reached over two million women and girls, averting nearly 18,000 maternal deaths. For this, we are eternally grateful.
As defence spending grows, we should not necessarily consider that security and international aid are competing priorities. They are interconnected. Strengthening health systems is not just the right thing to do – it reduces the risk of future instability, forced migration and protracted humanitarian crises. History has taught us this lesson.
Protecting progress on women's health and rights, built over decades, is a smart investment. For global development, for long-term stability and for the UK's role in the world.
From conflict zones in Afghanistan to refugee camps in Bangladesh and displaced communities in Myanmar, the people we serve are not asking for pity. They are asking for partnership and the chance to live healthy, dignified lives.
This is not only about UNFPA. It is about the UK's role in shaping a changing world, where global cooperation is under pressure but also where smart investments in health and stability still offer the best return.
When women and girls thrive, families are healthier, communities are stronger and the world is safer – for us all. So let's defend that midwife. Let's defend the rights of all our youth. Let's defend the promise of hope.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Experts pinpoint exactly how long you need to use a contraceptive pill to increase your risk of a brain tumour
Experts pinpoint exactly how long you need to use a contraceptive pill to increase your risk of a brain tumour

Daily Mail​

timea day ago

  • Daily Mail​

Experts pinpoint exactly how long you need to use a contraceptive pill to increase your risk of a brain tumour

Millions of women taking the mini-pill could be at increased risk of developing a brain tumour, new research suggests. Experts found that women taking the progestogen-only pill—often dubbed 'the mini-pill' continuously for more than five years were more likely to develop a meningioma. Meningiomas accounts for a third of all brain tumours diagnosed in the UK each year. While usually non-cancerous they can still cause problems they grow larger inside the brain. In the new study, French researchers analysed data from over 8,000 women, with an average age of 60, who had surgery for this form of tumour. They found women who did were more likely to have been taking the mini pill—medically called desogestrel for at least five years. However, independent experts have said women on the medication shouldn't panic, as the increased risk is relatively small. Desogestrel, in contrast to the more famous Pill, only contains one sex hormone progestogen. It is primarily taken by women with underlying health conditions that makes taking other contraceptives dangerous, or who suffer adverse side effects when doing so. The NHS says natural family planning can be up to 99 per cent effective when done correctly and around 75 per cent if not used according to instructions. By comparison, the Pill, implant, IUS and IUD are 99 per cent effective with perfect use, while condoms are 98 per cent While the increased risk of a meningioma was observed, the authors—who published their findings in the British Medical Journal —said it was relatively minor. They outlined that only one out of 67,000 women taking desogestrel will develop a meningioma requiring surgery. The scientists also found that there was no increased risk when the mini pill was used for less than five years. They also found that the increased risk disappeared a year after coming off the mini pill. Meningiomas are a tumour of the membrane that surrounds the brain, with more than 90 per cent of these are not cancerous. While not at risk of spreading elsewhere in the body like a cancerous growth they can still cause patients problems. Every year proportion of meningioma patients will need surgery to remove the tumour due to it causing increased internal pressure on the brain. Common symptoms of a meningioma include a persistent headache as well as constant nausea which is often accompanied with drowsiness. Dr Mangesh Thorat, an expert in population health at Queen Mary University of London, who was not involved in the study, said women on the medication shouldn't be alarmed. 'The magnitude of increase in the risk is small, and short-term use is not associated with increased risk and that the excess risk ceases to exist once the use is stopped for more than a year,' he said. He advised women who may be concerned about their risk to contact their GP. 'Talk to your healthcare provider regarding the drug you are using. If it is associated with an increased risk of meningioma, this can be changed to a safer alternative,' he said. Experts say that a limitation of the study is that the researchers only looked at one type of progestogen pill—desogestrel and not other drugs that also include the hormone. Dr Thorat said: 'the study cannot provide information on the formulations not commonly used in France but used in other countries.' He has called on further studies to be undertaken in different countries. Figures currently suggest around 6 per cent of women aged 16 to 49 use the mini pill in the UK—roughly 3.1 million patients. Taken every day, it works by thickening cervical mucus and thinning the womb lining which helps stop sperm reaching an egg and from a fertilised egg attaching itself in the womb. In some cases, the mini pill can also stop ovulation from occurring. It is 99.7 per cent effective with perfect use but if used incorrectly—such as missing a pill or experiencing nausea and diarrhoea while on it—around one in ten women (9 per cent) may get pregnant. Known side effects of the mini pill—proven to be over 99 per cent effective at stopping pregnancy—include nausea, breast tenderness, mood swings and headaches. Others claim they pile on pounds while taking the drug because of increased fluid retention and appetite. However, the NHS says there is no evidence it leads to weight gain. The latest study comes just a month after British scientists found that women with asthma who are taking the mini pill were a third more likely to suffer an attack.

NBA star looks unrecognizable with new look as he enters Chinese monastery after injury scare
NBA star looks unrecognizable with new look as he enters Chinese monastery after injury scare

Daily Mail​

timea day ago

  • Daily Mail​

NBA star looks unrecognizable with new look as he enters Chinese monastery after injury scare

NBA star Victor Wembanyama is currently in the middle of a retreat at a Chinese monastery where he looks unrecognizable with a shaved head. The 7-foot-3 Frenchman is in the middle of the 10-day exercise trying to stay as isolated as possible. Wembanyama can be seen praying in grey robes as well as running alongside a forest. The San Antonio Spurs sensation appeared in China in one of his first public appearances since his injury scare. Wembanyama was diagnosed with deep vein thrombosis in right shoulder in February, ending his season, with the Spurs believing it to be an 'isolated condition.' A vein thrombosis occurs when blood begins to clot in deeper veins in the body. The issue can become seriously dangerous because those clogs could loosen and end up in the lungs, causing a pulmonary embolism. Wemby is in China beginning his 'journey of inner discipline, focus, and mind-body harmony' at the Shaolin Temple According to a Buddhist monk, Wemby is on a ''Summer Retreat'' tradition that is tied back to ancient Buddhist practices (via @SpursGDP, @SpursReporter) — Bleacher Report (@BleacherReport) June 11, 2025 NBA star Victor Wembanyama is currently in the middle of a retreat at a Chinese monastery It is almost always treated with blood-thinning medication, which typically precludes a player from participating in a contact sport such as basketball. Athletes who are involved with contact sports are typically advised to avoid using such medication because of the heightened chance of bleeding. Wembanyama's injury came just days after first All-Star Game appearance. The 21-year-old Frenchman was the NBA's Rookie of the Year in 2023-24, as well as an All-Defensive First Team selection after leading the league in blocked shots. He was averaging 24.3 points, 11 rebounds, 3.8 blocks and 3.7 assists; the only other player to finish a season averaging all that was Kareem Abdul-Jabbar in 1975-76. The Spurs are positioned to make a jump with Wembanyama in his third year in the NBA, as he might not be the only superstar on his team come October. San Antonio is believed to be a major play in the sweepstakes for both Kevin Durant and Giannis Antetokounmpo.

I've lost the 4st I wanted to on Mounjaro - but there's not a chance I'm stopping now. This is why you'll have to physically prise the fat jabs out of my hands: JENNI MURRAY
I've lost the 4st I wanted to on Mounjaro - but there's not a chance I'm stopping now. This is why you'll have to physically prise the fat jabs out of my hands: JENNI MURRAY

Daily Mail​

timea day ago

  • Daily Mail​

I've lost the 4st I wanted to on Mounjaro - but there's not a chance I'm stopping now. This is why you'll have to physically prise the fat jabs out of my hands: JENNI MURRAY

In a week of scare stories surrounding fat jabs, you might think I'd be having second thoughts about my weekly Mounjaro jab. Not a chance. There is evidence that they could prevent hormone replacement drugs from working – putting the health of menopausal women at risk. Equally it seems unexpected, unwanted pregnancies are occurring in women on the contraceptive pill.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store